Securities and Exchange Commission
                             Washington, D.C.  20549



                                    FORM 8-K




                Current Report Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934





        Date of Report (Date of Earliest Event Reported): February 27, 2006




                        Commission File Number:   333-57780



                             INTERCARE DX, INC.
             (Exact name of registrants specified in its charter)

               California                          95-4304537

      (State or other jurisdiction of                (I.R.S. Employer
       incorporation or organization)                Identification No.)


                               6201 Bristol Parkway
                          Culver City California 90230
                       (213) 627-8878 Fax: (310) 743-0581



    (Address, Including Zip Code, And Telephone Number, Including Area Code,
                  Of Registrant's Principal Executive Offices)

































                                        1

SECTION  1.   Registrant's Business and Operations              Not  Applicable

SECTION  2.   Financial  Information                            Not  Applicable

SECTION  3.   Securities and Trading Markets                    Not  Applicable

SECTION  4.   Matters Relating to Accountants and
Financial Statements                                            Not  Applicable

SECTION  5.  Corporate governance and Management                Not  Applicable

SECTION  6.  Reserved                                           Not  Applicable

SECTION  7.  Regulation FD

On February 27, 2006, registrant  issued a press release announcing the result
of  shareholders vote at the 2006 annual shareholder meeting.

SECTION  8:  Other Events
On February  25,  2006,  the  following individuals  were  re-elected  to
serve as directors of  the  company  until the next annual meeting:  Jude
Uwaezoke,  Karunyan  Arulanantham,  Donald  Stanford and  Wesley  Bradford.
Anthony C. Dike, was re-elected for another three year term.

SECTION  9:  Financial Statements and Exhibits                 Not  Applicable

Exhibit 99.1
A Copy of press release announcing the results of shareholders vote at the
2006 annual shareholder meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the  Registrant  has  duly  caused this report to be signed on its behalf by the
undersigned  hereunto  duly  authorized.

                                        InterCare DX,  Inc.
                                          (Registrant)

Date:  February 27, 2006              By:/s/  Anthony  C.  Dike
                                      -------------------------
                                          Anthony  C.  Dike
                                 (Chairman, Chief Executive Officer)






























                                        2


Exhibit 99.1

FOR  IMMEDIATE  RELEASE:  6AM(EST) Monday, February 27,  2006


CONTACT:  Anthony C. Dike, MD (Chairman & CEO)
          InterCare  DX,  Inc
          213-627-8878
          www.intercare.com
          -----------------

                    INTERCARE DX, INC. HOLDS ANNUAL MEETING

Culver City, California--At  the annual meeting of InterCare  DX, Inc.  (OTC BB:
"ICCO"),  which  was   held  on  Saturday,  February  25,  2006,  the  following
individuals  were  re-elected  to  serve  as directors of  the company until the
next annual meeting: Jude Uwaezoke,  Karunyan  Arulanantham, Donald Stanford and
Wesley Bradford. Anthony C. Dike, was re-elected for another three year term.

Additionally, shareholders ratified the reappointment  of Madsen Associates CPA,
Inc., as  the  independent auditor for the fiscal year  ending December 31, 2005
and re-approved  the  Company's  2001  Joint  Incentive  and Non-Qualified Stock
Option Plan for fiscal year 2006.

Also,  shareholders  who  attended the  meeting  were  given  a  hands-on
demonstration of the Vasogram Technology to their overwhelming excitement.

A  copy  of  the  company's  Notice of Annual Meeting and Proxy Statement, which
details  each  of  the  aforementioned  approved proposals, may be viewed on the
SEC's  EDGAR  System  at  www.sec.gov.
                          -----------

About  InterCare  DX
InterCare  DX,  Inc.  an  affiliate  of  Meridian  Holdings,  Inc.(OTCBB: MRDH),
developed  and  markets  under  an exclusive value-added reseller agreement with
Meridian  Holdings,  Inc., InterCare Clinical Explorer    (ICE ), an innovative,
robust  and  totally  scalable  software application designed to integrate every
aspect  of  the  healthcare  enterprise.  InterCare  provides implementation and
support  for  the  ICE  ,  which  is  used  to  document and track inpatient and
outpatient  diagnoses  and  treatment  modalities  in  various  healthcare
environments,  ranging from individual practices to entire hospital systems. The
Company by initiating commercialization of the Vasogram Technology, will  be one
of  the few technology companies with a unique cardiovascular diagnostics device
in  the  market that is backed by extensive scientific studies and publications.
For  more  information  about  the  company and its products and services, visit
www.intercare.com.
    -------------

NOTE:  Statements  in  this  news  release  that  are  not purely historical are
forward-looking  statements  within the meaning of Section 27A of the Securities
Act  of 1933 and Section 21E of the Securities Exchange Act of 1934 and are made
pursuant  to  the  safe  harbor  provisions of the Private Securities Litigation
Reform  Act of 1995 and any amendments thereto. Material that is forward-looking
may  contain  statements  about  expected future events and/or financial results
that  are  forward-looking  in  nature. Editors and investors are cautioned that
such forward-looking statements invoke risk and uncertainties that may cause the
Company's results to differ from such forward-looking statements. These include,
but  are not limited to, economic, competitive, governmental, technological, and
other  factors  discussed in the statements and/or in the Company's filings with
the  Securities  and  Exchange  Commission.
                                      # # #




3